The 10 most frequently requested blood tests in the Capital Region of Denmark, 2010–2019 and simulated effect of minimal retesting intervals

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

The 10 most frequently requested blood tests in the Capital Region of Denmark, 2010–2019 and simulated effect of minimal retesting intervals. / Munk, Jens K.; Hansen, Margrethe F.; Buhl, Henrik; Lind, Bent S.; Bathum, Lise; Jørgensen, Henrik L.

I: Clinical Biochemistry, Bind 100, 2022, s. 55-59.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Munk, JK, Hansen, MF, Buhl, H, Lind, BS, Bathum, L & Jørgensen, HL 2022, 'The 10 most frequently requested blood tests in the Capital Region of Denmark, 2010–2019 and simulated effect of minimal retesting intervals', Clinical Biochemistry, bind 100, s. 55-59. https://doi.org/10.1016/j.clinbiochem.2021.11.002

APA

Munk, J. K., Hansen, M. F., Buhl, H., Lind, B. S., Bathum, L., & Jørgensen, H. L. (2022). The 10 most frequently requested blood tests in the Capital Region of Denmark, 2010–2019 and simulated effect of minimal retesting intervals. Clinical Biochemistry, 100, 55-59. https://doi.org/10.1016/j.clinbiochem.2021.11.002

Vancouver

Munk JK, Hansen MF, Buhl H, Lind BS, Bathum L, Jørgensen HL. The 10 most frequently requested blood tests in the Capital Region of Denmark, 2010–2019 and simulated effect of minimal retesting intervals. Clinical Biochemistry. 2022;100:55-59. https://doi.org/10.1016/j.clinbiochem.2021.11.002

Author

Munk, Jens K. ; Hansen, Margrethe F. ; Buhl, Henrik ; Lind, Bent S. ; Bathum, Lise ; Jørgensen, Henrik L. / The 10 most frequently requested blood tests in the Capital Region of Denmark, 2010–2019 and simulated effect of minimal retesting intervals. I: Clinical Biochemistry. 2022 ; Bind 100. s. 55-59.

Bibtex

@article{8c1e81e1135b413a85bf7ce061a053f8,
title = "The 10 most frequently requested blood tests in the Capital Region of Denmark, 2010–2019 and simulated effect of minimal retesting intervals",
abstract = "As healthcare costs continue to rise throughout the world, critical assessment of the appropriateness of expenses gain focus. Objectives: We aimed to describe the developments in test numbers of the 10 most frequently requested tests, and to simulate the effect of introducing minimal retesting intervals. Design & Methods: Data from the blood tests – albumin, alanine transaminase, cholesterol, creatinine, C-reactive protein, hemoglobin, hemoglobin A1c, potassium, sodium, and thyrotropin – from 2,687,589 patients handled by the Capital Region of Denmark from 2010 to 2019 was used. Tallies of each test per year were graphed. A simulation of the effect of minimal retesting intervals on test count and blood sampling volume was performed by virtually removing requests made prior to a set of possible minimal retesting intervals. Results: Increases in requests were observed both from hospitals and general practitioners. The number of requests for hemoglobin A1c increased more than the other tests. The increases could not be accounted for by an increase in population size and aging of the population, and therefore suggests possible inappropriate increase in monitoring of patients. The simulated effect of applying minimal retesting intervals showed large reductions in tests and blood sampled. Conclusions: For hospitals, the simulation suggested that applying minimal retesting intervals could lead to significant reductions in both the number of blood tests performed and in the amount of blood drawn for testing. For general practitioners, the simulation showed only minimal reductions in number of tests and blood volume drawn.",
keywords = "Big data, Frequently used blood tests, Laboratory information system, Minimal retesting interval, Simulation",
author = "Munk, {Jens K.} and Hansen, {Margrethe F.} and Henrik Buhl and Lind, {Bent S.} and Lise Bathum and J{\o}rgensen, {Henrik L.}",
note = "Publisher Copyright: {\textcopyright} 2021 The Author(s)",
year = "2022",
doi = "10.1016/j.clinbiochem.2021.11.002",
language = "English",
volume = "100",
pages = "55--59",
journal = "Clinical Biochemistry",
issn = "0009-9120",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - The 10 most frequently requested blood tests in the Capital Region of Denmark, 2010–2019 and simulated effect of minimal retesting intervals

AU - Munk, Jens K.

AU - Hansen, Margrethe F.

AU - Buhl, Henrik

AU - Lind, Bent S.

AU - Bathum, Lise

AU - Jørgensen, Henrik L.

N1 - Publisher Copyright: © 2021 The Author(s)

PY - 2022

Y1 - 2022

N2 - As healthcare costs continue to rise throughout the world, critical assessment of the appropriateness of expenses gain focus. Objectives: We aimed to describe the developments in test numbers of the 10 most frequently requested tests, and to simulate the effect of introducing minimal retesting intervals. Design & Methods: Data from the blood tests – albumin, alanine transaminase, cholesterol, creatinine, C-reactive protein, hemoglobin, hemoglobin A1c, potassium, sodium, and thyrotropin – from 2,687,589 patients handled by the Capital Region of Denmark from 2010 to 2019 was used. Tallies of each test per year were graphed. A simulation of the effect of minimal retesting intervals on test count and blood sampling volume was performed by virtually removing requests made prior to a set of possible minimal retesting intervals. Results: Increases in requests were observed both from hospitals and general practitioners. The number of requests for hemoglobin A1c increased more than the other tests. The increases could not be accounted for by an increase in population size and aging of the population, and therefore suggests possible inappropriate increase in monitoring of patients. The simulated effect of applying minimal retesting intervals showed large reductions in tests and blood sampled. Conclusions: For hospitals, the simulation suggested that applying minimal retesting intervals could lead to significant reductions in both the number of blood tests performed and in the amount of blood drawn for testing. For general practitioners, the simulation showed only minimal reductions in number of tests and blood volume drawn.

AB - As healthcare costs continue to rise throughout the world, critical assessment of the appropriateness of expenses gain focus. Objectives: We aimed to describe the developments in test numbers of the 10 most frequently requested tests, and to simulate the effect of introducing minimal retesting intervals. Design & Methods: Data from the blood tests – albumin, alanine transaminase, cholesterol, creatinine, C-reactive protein, hemoglobin, hemoglobin A1c, potassium, sodium, and thyrotropin – from 2,687,589 patients handled by the Capital Region of Denmark from 2010 to 2019 was used. Tallies of each test per year were graphed. A simulation of the effect of minimal retesting intervals on test count and blood sampling volume was performed by virtually removing requests made prior to a set of possible minimal retesting intervals. Results: Increases in requests were observed both from hospitals and general practitioners. The number of requests for hemoglobin A1c increased more than the other tests. The increases could not be accounted for by an increase in population size and aging of the population, and therefore suggests possible inappropriate increase in monitoring of patients. The simulated effect of applying minimal retesting intervals showed large reductions in tests and blood sampled. Conclusions: For hospitals, the simulation suggested that applying minimal retesting intervals could lead to significant reductions in both the number of blood tests performed and in the amount of blood drawn for testing. For general practitioners, the simulation showed only minimal reductions in number of tests and blood volume drawn.

KW - Big data

KW - Frequently used blood tests

KW - Laboratory information system

KW - Minimal retesting interval

KW - Simulation

U2 - 10.1016/j.clinbiochem.2021.11.002

DO - 10.1016/j.clinbiochem.2021.11.002

M3 - Journal article

C2 - 34774816

AN - SCOPUS:85119209874

VL - 100

SP - 55

EP - 59

JO - Clinical Biochemistry

JF - Clinical Biochemistry

SN - 0009-9120

ER -

ID: 285517980